Literature DB >> 3110995

Detection and quantitative evaluation of lupus circulating anticoagulant activity.

E Rosner, R Pauzner, A Lusky, M Modan, A Many.   

Abstract

Sixty-six SLE patients were studied for the presence of lupus type circulating anticoagulant. Forty-nine percent of them showed activity of this anticoagulant. The sensitivity of various coagulation tests was compared. Recalcification time was found to be the most sensitive screening test and the kaolin clotting time mixture test, the best for determining the presence of the anticoagulant. Tissue thromboplastin inhibition test detected only half of the patients in whom the anticoagulant was found by recalcification time and kaolin clotting time mixture test. APTT, using 2 different reagents, resulted in 73% and 52% false negatives. A numerical index for determining the presence of the anticoagulant and its quantitative evaluation is suggested. The association between thromboembolic events, recurrent abortions and the different coagulation tests is shown.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110995

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  19 in total

Review 1.  Influence of the lupus anticoagulant on clotting tests.

Authors:  J Vermylen; J Arnout
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

2.  Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus.

Authors:  H J Out; M van Vliet; P G de Groot; R H Derksen
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

3.  Factor V Leiden related Budd-Chiari syndrome.

Authors:  P Deltenre; M H Denninger; S Hillaire; M C Guillin; N Casadevall; J Brière; S Erlinger; D C Valla
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

4.  A Confounding Case of Inherited Factor V Deficiency Complicated by Inhibitors at First Presentation.

Authors:  Hema Subramanian; Rakhee Kar; Deepak Charles; Hitha Babu; Pagadalu Ambika; Tarun Kumar Dutta
Journal:  Transfus Med Hemother       Date:  2016-12-13       Impact factor: 3.747

5.  Low plasma protein Z levels in patients with ischemic colitis.

Authors:  Ioannis E Koutroubakis; Angeliki Theodoropoulou; Aekaterini Sfiridaki; Elias A Kouroumalis
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

6.  Lupus anticoagulant antibodies inhibit collagen-induced adhesion and aggregation of human platelets in vitro.

Authors:  I Ostfeld; N Dadosh-Goffer; S Borokowski; J Talmon; A Mani; U Zor; J Lahav
Journal:  J Clin Immunol       Date:  1992-11       Impact factor: 8.317

7.  Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.

Authors:  R H Derksen; P Hasselaar; L Blokzijl; F H Gmelig Meyling; P G De Groot
Journal:  Ann Rheum Dis       Date:  1988-05       Impact factor: 19.103

8.  Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients.

Authors:  S Hillaire; E Bonte; M-H Denninger; N Casadevall; J-F Cadranel; D Lebrec; D Valla; C Degott
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

9.  Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis.

Authors:  H L Staub; E N Harris; M A Khamashta; G Savidge; W H Chahade; G R Hughes
Journal:  Ann Rheum Dis       Date:  1989-02       Impact factor: 19.103

10.  Association of idiopathic hepatic sinusoidal dilatation with the immunological features of the antiphospholipid syndrome.

Authors:  D Saadoun; D Cazals-Hatem; M-H Denninger; L Boudaoud; B-N Pham; V Mallet; B Condat; J Brière; D Valla
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.